微创泪道再通联合置管治疗泪道阻塞

发布时间：2018-05-26 15:02

本文选题：泪道阻塞 + 泪道内窥镜　；参考：《实用医学杂志》2017年20期

【摘要】：目的探讨泪道内窥镜辅助下的微创泪道再通联合硅胶管植入术治疗泪道阻塞的临床疗效。方法收集上泪小管阻塞3例4眼、下泪小阻塞5例6眼,泪总管阻塞20例29眼,鼻泪管阻塞25例36眼。随机分为两组,分别是泪道内窥镜辅助下的激光泪道成形联合泪道置管组(A组40只眼)、泪道内窥镜辅助下的微钻成形联合泪道置管组(B组35只眼)。治疗后随访3~6个月。结果除术中出血外,两种手术方式各种并发症的发生率未见明显区别。A组患者泪道再通总有效率达到87.50%;B组患者泪道再通总有效率达到91.43%,差异没有统计学意义。结论泪道内窥镜辅助下的微创泪道再通联合硅胶管植入治疗泪道阻塞是一种安全、有效的方法,损伤小,恢复快,并发症少。
[Abstract]:Objective to investigate the clinical effect of minimally invasive lacrimal duct recanalization combined with silicone tube implantation in the treatment of lacrimal duct obstruction. Methods 3 cases (4 eyes) of superior lacrimal canaliculus obstruction, 5 cases (6 eyes) of inferior lacrimal obstruction, 20 cases (29 eyes) of common lacrimal duct obstruction and 25 cases (36 eyes) of nasolacrimal duct obstruction were collected. Two groups were randomly divided into two groups: laser lacrimal duct formation assisted by endoscope and lacrimal duct placement group (group A, 40 eyes), and lacrimal duct endoscope assisted microdrilling combined with lacrimal duct placement group (group B, 35 eyes). The patients were followed up for 3 ~ 6 months after treatment. Results except for intraoperative bleeding, there was no significant difference in the incidence of complications between the two operative methods. The total effective rate of lacrimal duct recanalization in group A was 87.50%. The total effective rate of lacrimal duct recanalization in group B was 91.43. The difference was not statistically significant. Conclusion minimally invasive recanalization of lacrimal passage and silicone tube implantation under endoscope is a safe and effective method for the treatment of lacrimal duct obstruction with less injury, faster recovery and fewer complications.
【作者单位】：广州医科大学附属第二医院眼科中心;
【基金】：国家自然科学基金项目(编号:81300732) 广东省自然科学基金项目(编号:2014A030313487) 广州市属高校“羊城学者”青年科研骨干培养项目(编号:1201581612) 广州市医药卫生科技项目(编号:20171A010309)
【分类号】：R779.6

【相似文献】